A protein modification of the gene expression regulator MECP2 can convey neuroprotection under inflammation. Researchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a therapeutic target in early Alzheimer’s disease. The new study investigated the role of MECP2, a regulator of gene expression, in […]
Read More… from Neuroprotection in the early stages of Alzheimer’s